Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IFOSFAMIDE Cause Encephalitis cytomegalovirus? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Encephalitis cytomegalovirus have been filed in association with IFOSFAMIDE (IFEX). This represents 0.1% of all adverse event reports for IFOSFAMIDE.

10
Reports of Encephalitis cytomegalovirus with IFOSFAMIDE
0.1%
of all IFOSFAMIDE reports
10
Deaths
5
Hospitalizations

How Dangerous Is Encephalitis cytomegalovirus From IFOSFAMIDE?

Of the 10 reports, 10 (100.0%) resulted in death, 5 (50.0%) required hospitalization, and 6 (60.0%) were considered life-threatening.

Is Encephalitis cytomegalovirus Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IFOSFAMIDE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does IFOSFAMIDE Cause?

Off label use (2,281) Febrile neutropenia (2,225) Disease progression (1,912) Neutropenia (1,509) Drug ineffective (1,331) Thrombocytopenia (1,227) Anaemia (1,067) Product use in unapproved indication (890) Pyrexia (752) Sepsis (712)

What Other Drugs Cause Encephalitis cytomegalovirus?

GANCICLOVIR (150) CYCLOPHOSPHAMIDE (134) RITUXIMAB (125) FOSCARNET (120) VALGANCICLOVIR (117) CYCLOSPORINE (116) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (75) HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN (72) BUDESONIDE (69) MYCOPHENOLATE MOFETIL (58)

Which IFOSFAMIDE Alternatives Have Lower Encephalitis cytomegalovirus Risk?

IFOSFAMIDE vs IGURATIMOD IFOSFAMIDE vs ILOPERIDONE IFOSFAMIDE vs ILOPROST IFOSFAMIDE vs IMATINIB IFOSFAMIDE vs IMBRUVICA

Related Pages

IFOSFAMIDE Full Profile All Encephalitis cytomegalovirus Reports All Drugs Causing Encephalitis cytomegalovirus IFOSFAMIDE Demographics